BiotechTubeBiotechTube
Home/Ventyx Biosciences/Mark S. Forman, MD, PhD
MS

Mark S. Forman, MD, PhD

Chief Medical Officer

Ventyx Biosciences

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesNeurodegenerative DiseasesCardiometabolic Diseases

Ventyx Biosciences Pipeline

DrugIndicationPhase
VTX2735Recurrent PericarditisPhase 2
VTX3232Neurodegenerative and Cardiometabolic Diseases (e.g., Parkinson's, Alzheimer's, ALS)Phase 2
TamuzimodInflammatory Bowel Disease (IBD)Phase 2
VTX958Inflammatory Bowel Disease (IBD)Phase 2

Leadership Team at Ventyx Biosciences

RM
Raju Mohan, PhD
Founder, Chief Executive Officer & Director
MM
Matthew Moore
Chief Operating Officer
View full Ventyx Biosciences profile